(19)
(11) EP 1 159 441 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.10.2008 Bulletin 2008/44

(45) Mention of the grant of the patent:
17.09.2008 Bulletin 2008/38

(21) Application number: 00909483.0

(22) Date of filing: 10.03.2000
(51) International Patent Classification (IPC): 
C12N 15/87(2006.01)
C07K 14/035(2006.01)
 C12N 15/88(2006.01)
A61K 47/00(2006.01)
(86) International application number:
PCT/GB2000/000897
(87) International publication number:
WO 2000/053722 (14.09.2000 Gazette 2000/37)

(54)

DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS

VERABREICHUNG VON NUKLEINSÄUREN UND PROTEINEN AN ZELLEN

ADMINISTRATION DE SUBSTANCES A DES CELLULES

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 10.03.1999 GB 9905444
24.12.1999 GB 9930499

(43) Date of publication of application:
05.12.2001 Bulletin 2001/49

(73) Proprietor: Marie Curie Cancer Care
London SE1 7TP (GB)

(72) Inventors:
  • O'HARE, Peter Francis Joseph
    Oxted, Surrey RH8 0TL (GB)
  • NORMAND, Nadia Michelle
    92100 Boulogne-Billancourt (FR)

(74) Representative: Kremer, Simon Mark et al
Mewburn Ellis LLP York House, 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)


(56) References cited: : 
WO-A-97/05265
WO-A-98/32866
 WO-A-97/24453
   
  • PHELAN A ET AL: "Intercellular delivery of functional p53 by the herpesvirus protein VP22." NATURE BIOTECHNOLOGY, vol. 16, no. 5, May 1998 (1998-05), pages 440-443, XP002157802 ISSN: 1087-0156
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).